Lundbeck wants Merck EVP as board member
Following Vestas CEO Henrik Andersen's decision to leave Lundbeck's board the pharmaceutical firm has found his replacement at German company Merck.
BY RITZAU FINANS, TRANSLATED BY NIELSINE NIELSEN
Lundbeck nominates Dorothea Wenzel to replace Henrik Andersen on the board, since he will not be running again.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Novo Nordisk lines up for May Alzheimer's trial
For subscribers
.jpg&w=384&q=75)
